Highest-materiality recent filing
HealthStream: annual meeting votes pass; directors elected, auditor ratified, say-on-pay approved
Class II directors elected: Jahangir (22.4M for, 2.4M withheld), McLaren (14.5M for, 10.4M withheld), Rebrovick (23.3M for, 1.6M withheld).
HealthStream promotes Collier to COO/EVP; grants options to Collier and CEO Frist
Michael M. Collier promoted to COO and EVP effective May 4, 2026; will lead enterprise operations, M&A, and AI transformation.
HealthStream Q1 revenue up 10.5% to $81.2M; EPS $0.20; promotes Collier to COO
Q1 revenue $81.2M (+10.5%), operating income $7.5M (+71.6%), net income $5.9M (+36.4%), diluted EPS $0.20 vs $0.14.
Board authorized repurchase of up to $10M of common stock; program expires Sept 12, 2026.
HealthStream Q4 revenue $79.7M (+7.4%); adj. EPS $0.18; GAAP EPS $0.09 on CEO stock gift
FY revenue $304.1M (+4.3%), adj. EBITDA $71.8M (+7.5%); Q4 revenue $79.7M (record, +7.4%).
HealthStream acquires MissionCare Collective for up to $40M; adds myCNAjobs caregiver network
Purchase price up to $40M: $26M cash, ~$4M in HSTM stock at close, $10M earnout over 3 years.
HealthStream CEO contributes $3.5M in personal shares to reward 700+ employees
CEO Robert Frist contributed 146,286 personal shares (~$3.5M) for immediate grant to over 700 non-executive employees.
HealthStream announces $10M share repurchase program expiring Feb 2026
Board authorized up to $10M buyback of HSTM common stock under new program.
Q3 revenue $76.5M (record), +4.6% YoY; net income $6.1M, EPS $0.20; adjusted EBITDA $19.1M (record), +7.9% YoY.
HealthStream acquires Virsys12 for up to $17M to expand payer credentialing
HealthStream (HSTM) acquires Virsys12, a healthcare tech firm for payer provider data management and credentialing.
HealthStream Q2 revenue $74.4M record (+4%), EPS $0.18, raises FY net income guidance
Q2 revenues $74.4M (+4.0%), operating income $5.9M (+33.4%), net income $5.4M (+29.3%).
Charles E. Beard, Jr., Thompson S. Dent, and Deborah Taylor Tate elected as Class I directors with 26.6M, 23.8M, and 24.9M votes for, respectively.
HealthStream Board authorizes $25M share repurchase program through May 2026
Board approved repurchase of up to $25M of outstanding common stock, no par value.
HealthStream Q1 revenue up 1% to $73.5M; lowers FY2025 guidance on tech scaling, macro headwinds
Q1 EPS $0.14 (diluted), down from $0.17; net income $4.3M, down 17.1% YoY.
Director William W. Stead to retire from HealthStream board at annual meeting
Stead notified company on March 24, 2025; effective at 2025 annual stockholders meeting.
Subleases 9th and 10th floors of Capitol View building; retains 8th floor as HQ in Nashville.
HealthStream appoints Charles E. Beard, Jr. to board of directors
Charles E. Beard, Jr. appointed to HealthStream board effective March 7, 2025, as Class I director with term expiring at 2028 annual meeting.
HealthStream announces EVP Sousa resignation and promotions of Collier, Coady, O'Hara
Michael Sousa resigns as EVP, Enterprise Applications, effective March 31, 2025.
HealthStream Q4 revenue up 5.2% to $74.2M, EPS $0.16; raises dividend 10.7% to $0.031
Q4 revenues $74.2M (+5.2% YoY), operating income $4.7M (+10.2%), net income $4.9M (+6.5%), diluted EPS $0.16.
HealthStream Q3 revenue $73.1M (+3.9% YoY), EPS $0.19, raises net income guidance
Revenue $73.1M (+3.9% YoY); net income $5.7M (+48%); diluted EPS $0.19 vs $0.13.
HealthStream Q2 revenue $71.6M (+3.4%), EPS $0.14, updates FY2024 guidance
Q2 revenue $71.6M (+3.4% YoY), operating income $4.4M (+10.1%), net income $4.2M (+0.8%), diluted EPS $0.14 vs $0.13.
HealthStream shareholders re-elect three directors, ratify EY, approve say-on-pay
Robert A. Frist, Jr. re-elected with 25.3M votes (0.9M withheld); Frank Gordon with 24.0M (2.2M withheld); Terry A. Rappuhn with 25.7M (0.4M withheld).
HealthStream Q1 revenue $72.8M (+6% YoY); net income +99%, EPS $0.17; reaffirms FY 2024 guidance
Revenue $72.8M, up 6% from $68.9M; subscription revenue grew 6% to $4.2M.
HealthStream Q4 net income +87% to $4.6M; raises quarterly dividend 12%
Q4 revenue $70.6M (+3% YoY); net income $4.6M (+87%); diluted EPS $0.15 vs $0.08 in Q4 2022.
HealthStream Q3 2023 revenue $70.3M (+5% YoY), EPS $0.13; raises adjusted EBITDA guidance
Revenue $70.3M (+5% YoY), operating income $4.9M (+104%), net income $3.9M (+5%), diluted EPS $0.13 (from $0.12).
HealthStream amends bylaws to enhance shareholder nomination procedures
Adopted October 23, 2023; effective immediately.
HealthStream enters $50M amended revolving credit facility with Truist Bank
New $50M unsecured revolving credit facility replaces existing senior secured facility.
HealthStream authorizes $10M share repurchase program through March 31, 2024
Board approved repurchase of up to $10M of HSTM common stock.
HealthStream Q2 revenue up 5% to $69.2M, EPS $0.13; reaffirms 2023 guidance
Revenue $69.2M (+5% YoY); operating income $4.0M (+36%); net income $4.1M (+34%).
HealthStream appoints Dr. Alex Jahangir to Board of Directors
Dr. Jahangir appointed effective May 30, 2023 as Class II Director with term expiring at 2026 annual meeting.
HealthStream shareholders elect directors, ratify auditor, approve say-on-pay
Elected Jeffrey L. McLaren (14.4M for, 12.7M withheld) and Linda Rebrovick (20.0M for, 7.0M withheld) as Class II directors.
HealthStream Q1 revenue up 5% to $68.9M; EPS $0.09; reaffirms FY23 guidance
Revenue $68.9M (+5% YoY); subscription revenue up 6% to partially offset professional services decline.
HealthStream declares first quarterly cash dividend of $0.025 per share
Dividend of $0.025 per share payable April 28, 2023 to holders of record April 17, 2023.
Director Michael D. Shmerling to retire from HealthStream board at 2023 annual meeting
Michael D. Shmerling notified HealthStream on March 27, 2023, he will not stand for re-election as Class II director.
J. Edward Pearson, President & COO, to retire at end of Q2 2023; will continue as part-time Executive-in-Residence.
HealthStream Q4 revenue $68.5M (+7% YoY), net income $2.5M; initiates $0.025 quarterly dividend
Q4 2022 revenue $68.5M (+7% YoY); net income $2.5M vs loss $0.4M; EPS $0.08 vs -$0.01.
HealthStream acquires eeds for $7M cash, completing CME management buy spree
Acquired substantially all assets of eeds for approximately $7.0 million in cash, subject to post-closing adjustments.
HealthStream Q3 revenue $67.3M (+5% YoY), net income $3.7M (+144%), updates 2022 guidance
Revenue $67.3M (+5% YoY); net income $3.7M (+144%); diluted EPS $0.12 vs $0.05.
HealthStream Q2 revenue up 1% to $65.6M; EPS $0.10; reaffirms FY guidance
Revenue $65.6M (+1% YoY); operating income $3.0M (-14%); net income $3.1M (+26%); diluted EPS $0.10 (vs $0.08).
HealthStream shareholders elect three Class I directors, approve 2022 Omnibus Incentive Plan
Elected Thompson S. Dent, William W. Stead, and Deborah Taylor Tate as Class I directors for three-year terms.
HealthStream acquires remaining equity of CloudCME for ~$8.2M in cash and stock
Purchase price: ~$4.08M cash plus 208,567 shares (~$4.08M); total ~$8.16M.
HealthStream Q1 Revenue $65.4M, EPS $0.09; Expands Buyback by $10M; Reaffirms Guidance
Revenue $65.4M (+3% YoY); Workforce Solutions $52.0M (+2%), Provider Solutions $13.3M (+9%).
HealthStream expands share repurchase authorization by $10M
Board authorized repurchase of up to $10M additional common stock through March 13, 2023.
HealthStream Q4 revenue up 4% to $64.3M, net loss $0.4M; full-year adj EBITDA record $52.7M
Q4 operating loss $0.5M vs income $1.1M; $2.4M stock-comp charge from CEO's share gift to 1,000+ employees.
HealthStream appoints Terry Allison Rappuhn to Board of Directors; will serve on Audit Committee
Appointment effective January 10, 2022; Ms. Rappuhn is a Class III Director with term through 2024 annual meeting.
HealthStream CEO contributes $2.25M in personal shares to reward 1,000+ employees
CEO Robert A. Frist, Jr. contributed 86,494 shares ($2.25M) for immediate grant to non-executive employees.
HealthStream acquires Rievent Technologies for $4M in cash
Acquired substantially all assets of Rievent, a SaaS-based CME/CE management application, for ~$4.0M in cash.
HealthStream board authorizes $20M share repurchase program through Nov 2022
Board approved repurchase of up to $20 million of outstanding common stock.
HealthStream Q3 revenue up 5% to $64.1M; EPS down to $0.05; FY2021 EBITDA guidance $51-53M
Revenues $64.1M (+5% YoY); operating income $1.8M (-43%); net income $1.5M (-43%); EPS $0.05 vs $0.08 YoY.
HealthStream Q2 revenue up 7% to $64.8M; net income down 29%; updates FY2021 guidance
Revenue $64.8M (+7% YoY); operating income $3.4M (-20%); net income $2.4M (-29%); EPS $0.08 vs $0.11.
Michael M. Collier has been promoted to the Company’s Chief Operating Officer and Executive Vice President from his prior role as the Company’s EVP, Corporate Strategy, Development & Operations.
On March 24, 2025, William W. Stead, M.D. notified HealthStream, Inc. (the “Company”) that he has decided not to stand for re-election to the Company’s Board of Directors (the “Board”) as a Class I director at the Company’s annual meeting of stockholders and to retire from service on the Board effective concurrently with this annual meeting.
On March 7, 2025, the Board of Directors (the “Board”) of HealthStream, Inc. (the “Company”) appointed Charles E. Beard, Jr. as a member of the Board.
On February 24, 2025, the Company also announced in the Earnings Release that Trisha Coady was being promoted to the Company’s EVP, Workforce Development Solutions from her prior role as SVP, Workforce Development Solutions.
On February 24, 2025, HealthStream, Inc. (the “Company”) received notice that Michael Sousa, Executive Vice President, Enterprise Applications intends to resign from his current position at the Company effective March 31, 2025.
On February 24, 2025, the Company announced in the Earnings Release that Michael Collier was being promoted to the Company’s EVP, Corporate Strategy, Development & Operations from his prior role as the Company’s EVP, Corporate Strategy & Development.
On May 30, 2023, the Board of Directors (the “Board”) of HealthStream, Inc. (the “Company”) appointed Dr. Alex Jahangir as a member of the Board.
On March 27, 2023, Michael D. Shmerling notified HealthStream, Inc. (the “Company”) that he has decided not to stand for re-election to the Company’s Board of Directors (the “Board”) as a Class II director at the Company’s 2023 annual meeting of stockholders and to retire from service on the Board effective concurrently with this annual meeting.
On February 20, 2023, J. Edward Pearson, President & Chief Operating Officer of HealthStream, Inc. (the "Company"), provided notice to the Company that he will be retiring from his current role in these positions effective at the end of the second quarter of 2023.
Pursuant to the terms of this Agreement, effective February 20, 2023, Mr. Sousa will serve as the Executive Vice President, Enterprise Applications of the Company, with anticipated increases in responsibilities, and potential future changes in title, over the next five years.
On January 6, 2022, the Board of Directors (the “Board”) of HealthStream, Inc. (the “Company”) appointed Terry Allison Rappuhn as a member of the Board.
Max materiality 0.80 · Median 0.55 · Most common event earnings